跳轉至內容
Merck
全部照片(1)

重要文件

CBL415

Sigma-Aldrich

Anti-Thy-1 Antibody, clone F15-42-1

clone F15-42-1, Chemicon®, from mouse

同義詞:

CD90

登入查看組織和合約定價


About This Item

分類程式碼代碼:
12352203
eCl@ss:
32160702
NACRES:
NA.41

生物源

mouse

品質等級

抗體表格

purified antibody

抗體產品種類

primary antibodies

無性繁殖

F15-42-1, monoclonal

物種活性

human

製造商/商標名

Chemicon®

技術

flow cytometry: suitable
immunohistochemistry: suitable
immunoprecipitation (IP): suitable

同型

IgG1

NCBI登錄號

UniProt登錄號

運輸包裝

wet ice

基因資訊

human ... THY1(7070)

特異性

Thy-1 molecule is heavily glycosylated membrane bound protein of 18 kDa.

應用

Anti-Thy-1 Antibody, clone F15-42-1 is an antibody against Thy-1 for use in FC, IP, IH.
Studies of frozen, unfixed tissue sections of Thy.1 antigen, notably in studies of neuroblastoma, leukaemia phenotyping and carcinoma of the breast

Studies of renal corticol fibroblasts in progressive renal disease.

Epitope is resistant to trypsin treatment used to release adherent cells from surfaces. Antibody not tested in fixed tissue.

Optimal working dilutions must be determined by the end user.

聯結

Replaces: CBL1354

外觀

Format: Purified

法律資訊

CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany

未找到適合的產品?  

試用我們的產品選擇工具.

儲存類別代碼

12 - Non Combustible Liquids

水污染物質分類(WGK)

WGK 2

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析證明 (COA)

輸入產品批次/批號來搜索 分析證明 (COA)。在產品’s標籤上找到批次和批號,寫有 ‘Lot’或‘Batch’.。

已經擁有該產品?

您可以在文件庫中找到最近購買的產品相關文件。

存取文件庫

A Clayton et al.
Journal of the American Society of Nephrology : JASN, 8(4), 604-615 (1997-04-01)
Progressive renal disease is frequently accompanied by renal interstitial inflammation and fibrosis in which the activity of resident fibroblasts may be of central importance. Because there are relatively few fibroblasts in the normal cortical interstitium and there is no specific
Distribution of Thy-1 in human brain: immunofluorescence and absorption analyses with a monoclonal antibody.
McKenzie, J L and Fabre, J W
Brain Research, 230, 307-316 (1981)
Arantxa Blázquez-Prunera et al.
Stem cell research & therapy, 8(1), 103-103 (2017-04-30)
Mesenchymal stem cells (MSCs) show promising characteristics for their use in advanced therapy medicinal products. However, there are some unresolved concerns, such as the use of animal components for their expansion. In this study we assessed the suitability of a

文章

Development of a novel serum-free and xeno-free human mesenchymal stem cell (MSC) osteocyte differentiation media.

新型无血清、无异种人间充质干细胞(MSC)骨细胞分化培养基的开发。

我們的科學家團隊在所有研究領域都有豐富的經驗,包括生命科學、材料科學、化學合成、色譜、分析等.

聯絡技術服務